CAAS CAPITAL MANAGEMENT LP - AMBRX BIOPHARMA INC ownership

AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 20 filers reported holding AMBRX BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAAS CAPITAL MANAGEMENT LP ownership history of AMBRX BIOPHARMA INC
ValueSharesWeighting
Q4 2021$118,000
-78.1%
13,068
-67.3%
0.00%
-72.7%
Q3 2021$540,000
-31.1%
40,0000.0%0.01%
-15.4%
Q2 2021$784,00040,0000.01%
Other shareholders
AMBRX BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Fosun International Ltd 1,932,591$5,121,0000.71%
Cormorant Asset Management, LP 2,486,386$6,589,0000.50%
Artal Group S.A. 2,152,291$5,704,0000.30%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,491,832$3,953,0000.15%
Octagon Capital Advisors LP 122,800$325,0000.09%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,027,291$5,372,0000.01%
TUDOR INVESTMENT CORP ET AL 19,063$51,0000.00%
FMR LLC 3,857,679$10,223,0000.00%
Renaissance Technologies 11,000$29,0000.00%
UBS Group AG 242$1,0000.00%
View complete list of AMBRX BIOPHARMA INC shareholders